MARAMPON, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 992
EU - Europa 718
AS - Asia 151
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 1.868
Nazione #
US - Stati Uniti d'America 988
IE - Irlanda 334
CN - Cina 111
DE - Germania 85
SE - Svezia 79
IT - Italia 72
UA - Ucraina 45
BE - Belgio 38
GB - Regno Unito 33
TR - Turchia 31
FR - Francia 15
VN - Vietnam 7
FI - Finlandia 6
AU - Australia 3
CA - Canada 3
EU - Europa 3
PT - Portogallo 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
JP - Giappone 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
Totale 1.868
Città #
Dublin 330
Chandler 306
Jacksonville 183
Ann Arbor 63
Brussels 38
Lawrence 34
Princeton 34
Wilmington 34
L'aquila 33
Bremen 32
Beijing 27
Nanjing 27
Izmir 24
Woodbridge 16
San Mateo 15
Boardman 12
Falls Church 12
Grafing 12
Des Moines 10
Shenyang 9
Washington 9
Cambridge 8
Mountain View 8
Dearborn 7
Milan 7
Seattle 7
Changsha 6
Dong Ket 6
Hebei 6
Nanchang 6
Norwalk 6
Kunming 5
Tianjin 5
Hanover 4
Napoli 4
Ashburn 3
Houston 3
Jinan 3
Shanghai 3
Tappahannock 3
Verona 3
Zhengzhou 3
Bolton 2
Braga 2
Fremont 2
Guangzhou 2
Jiaxing 2
Lanzhou 2
Menlo Park 2
Ningbo 2
Piombino Dese 2
Redwood City 2
Rome 2
Saint Paul 2
Toronto 2
Vittuone 2
Adliswil 1
Amsterdam 1
Beauharnois 1
Bellante 1
Canberra 1
Carlentini 1
Cedar Knolls 1
Cormeilles-en-Parisis 1
Detroit 1
Edinburgh 1
Fairfield 1
Gainesville 1
Gold Hill 1
Hanoi 1
Irkutsk 1
Lodi 1
Logan 1
Madrid 1
Moscow 1
Nanning 1
Panama City 1
San Diego 1
Sydney 1
Taizhou 1
Tel Aviv 1
Teramo 1
Tokyo 1
Vienna 1
Villeneuve 1
Warsaw 1
Totale 1.424
Nome #
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 102
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 90
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 88
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 87
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors 79
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 77
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 75
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 73
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis 73
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson's Disease 68
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity 63
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models 61
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 61
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 57
The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs 56
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 55
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models 54
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 51
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 51
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 50
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 45
Parkinson's disease and light: The bright and the Dark sides 45
A New Threat to Dopamine Neurons: The Downside of Artificial Light 44
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 42
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 42
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 41
Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics 41
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 36
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 36
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 34
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 34
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 31
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 31
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 28
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications 17
Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging 11
Totale 1.929
Categoria #
all - tutte 5.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019119 0 0 2 2 2 5 43 4 4 13 2 42
2019/2020224 37 1 19 4 3 39 40 4 30 17 5 25
2020/2021267 5 27 11 27 27 9 36 2 43 12 52 16
2021/2022249 11 2 38 12 12 21 9 7 36 20 15 66
2022/2023898 49 69 12 124 61 85 2 49 402 9 24 12
2023/202454 21 15 18 0 0 0 0 0 0 0 0 0
Totale 1.929